DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Fine RL, Gulati AP, Krantz BA. et al.
Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience.
Cancer Chemother Pharmacol 2013;
71 (03) 663-670
We do not assume any responsibility for the contents of the web pages of other providers.